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ABSTRACT
Sixty diverse clinical Acinetobacter baumannii isolates of worldwide origin were assigned to sequence
groups, based on a multiplex PCR for the ompA, csuE and blaOXA-51-like genes. The majority (77%) of
isolates belonged to sequence groups 1 and 2 (SG1 and SG2), with sequence group 3 (SG3) and non-
grouped isolates accounting for the remainder. The isolates were not closely related according to pulsed-
ﬁeld gel electrophoresis (PFGE), and the majority were sensitive to imipenem and meropenem. The
construction of a linkage map of OXA-51-like b-lactamase sequence relationships revealed two closely
related clusters of enzymes, one focused around OXA-66 and the other around OXA-69. Isolates
belonging to SG1 encoded an enzyme from the OXA-66 cluster, while those belonging to SG2 encoded
an enzyme from the OXA-69 cluster. All SG3 isolates encoded OXA-71, which does not form part of a
close enzyme grouping. Major multinational lineages accounted for a signiﬁcant proportion of
A. baumannii clinical isolates, and the evolution of the OXA-51-like enzymes appears to be an ongoing
process.
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INTRODUCTION
Acinetobacter baumannii is an important Gram-
negative nosocomial pathogen responsible for
serious infections in immunocompromised
patients, particularly in intensive care units [1,2].
Infections are often difﬁcult to treat because of the
development of antimicrobial resistance, and
particularly because of the emergence of carba-
penem-hydrolysing b-lactamases, since carbapen-
ems are now the drugs of choice for the treatment
of Acinetobacter infections [3,4]. Carbapenem-
resistant A. baumannii strains have been described
as endemic since 1997 [5], and carbapenem
resistance in A. baumannii has been described as
a global sentinel event for emerging antimicrobial
resistance [4]. In particular, the identiﬁcation of
three major lineages (termed European clones I, II
and III), prevalent in hospitals across Europe,
highlights the ability of successful lineages of this
organism to disseminate widely [6–8].
Since the ﬁrst report of an OXA-type carbape-
nemase in an A. baumannii isolate from 1985 [9],
reports of class D b-lactamases have become
common, and their contribution to high-level
carbapenem resistance within strains of A. bau-
mannii has been demonstrated [9,10]. The class D
b-lactamase OXA-51 was ﬁrst identiﬁed in A. bau-
mannii in 2004 [11], and minor variations in the
sequence encoding OXA-51 have subsequently
been reported, constituting the OXA-51-like sub-
group of enzymes [12–15]. It has been suggested
that blaOXA-51-like genes are ubiquitous in A. bau-
mannii, and that insertion of ISAba1 upstream of
the genes may provide a promoter to enhance
gene expression, potentially contributing to
increased levels of resistance to carbapenems
[14,16]. As these genes are apparently ubiquitous
and unique to A. baumannii, it has been proposed
that identiﬁcation of this species can be based
simply on the detection of an OXA-51-like
enzyme [17].
Corresponding author and reprint requests: S. G. B. Amyes,
Molecular Chemotherapy, Centre for Infectious Diseases, The
University of Edinburgh, Room SU.312, The Chancellor’s
Building, 49 Little France Crescent, Edinburgh, EH16 4SB, UK
E-mail: s.g.b.amyes@ed.ac.uk
 2008 The Authors
Journal Compilation  2008 European Society of Clinical Microbiology and Infectious Diseases
Sequence typing of 31 A. baumannii isolates,
predominantly from the UK, using speciﬁc
regions of blaOXA-51-like genes, the ompA gene
(encoding the porin outer-membrane protein A)
and the csuE gene (encoding a product important
in a pilus chaperone–usher secretion system), has
revealed three distinct lineages or sequence
groups [18]. Interestingly, each sequence group
was found to correspond to three predominant
European lineages designated as European clones
I, II and III. Also, three blaOXA-51-like alleles,
corresponding to the three main sequence
groups, were identiﬁed as blaOXA-66, blaOXA-69
and blaOXA-71, respectively.
There are currently 37 members of the OXA-51-
like group of enzymes, varying in structure by
between one and 16 amino-acids. The present
study aimed to investigate the relationships
among the OXA-51-like enzyme family, together
with the association of these enzymes with
particular clonal groupings found among epi-
demic lineages and temporally diverse isolates of
A. baumannii obtained from worldwide sources.
MATERIALS AND METHODS
Bacterial isolates
Sixty A. baumannii isolates were collected between 1982 and
2006 from hospitals worldwide (Fig. 1). Isolates were initially
identiﬁed in the individual hospital laboratories using stan-
dard microbiological techniques, and were then conﬁrmed as
members of the A. baumannii complex [1] by tRNA ﬁnger-
printing [19].
PCR ampliﬁcation and sequence analysis of blaOXA-51-like
genes
All primers used in this study are listed in Table 1. DNA
extraction was performed by boiling up to three colonies in
50 lL of sterile distilled water for 10 min. PCRs were per-
formed in 50-lL volumes containing 20 mM Tris-HCl (pH 8.8),
10 mM KCl, 10 mM (NH4)2SO4, 2 mM MgSO4, nuclease-free
bovine serum albumin 0.1 mg ⁄mL, Triton X-100 0.1% v ⁄v,
1.5 mM MgCl2, 800 lM PCR nucleotide mix, and 1.25 U of Pfu
DNA polymerase (Promega, Southampton, UK). The primers
OXA-69A and OXA-69B [12] were used to amplify a 975-bp
fragment containing the blaOXA-51-like gene under the following
conditions: 95C for 2 min, followed by 30 cycles of 95C for
1 min, 48C for 40 s and 72C for 3 min, followed by 72C for
6 min. For isolates that produced a product larger than 975 bp
because of the presence of ISAba1 upstream of the blaOXA-51-like
gene, the primer preABprom+ [20] was used with OXA-69B to
produce a 1189-bp product under the same cycling conditions,
except that the annealing temperature was increased to 53C.
Reactions were carried out in a Px2 Thermal Cycler (Thermo
Fisher Scientiﬁc, Waltham, MA, USA) using primer concen-
trations of 25 pmol ⁄lL and 0.5 lL of template DNA. PCR
products were analysed on agarose 1.5% w ⁄v gels stained
with ethidium bromide, and were then scanned using the
Diversity Database software image-capturing system (Bio-Rad,
Hemel Hempstead, UK). Products were puriﬁed using a
QIAquick PCR Puriﬁcation Kit (Qiagen, Crawley, UK) and
were sequenced in both directions on a 3730 DNA Analyzer
(Applied Biosystems, Warrington, UK). Sequences were anal-
ysed using BLAST (http://www.ncbi.nlm.nih.gov/BLAST/)
and MultAlin (http://bioinfo.genopole-toulouse.prd.fr/
multalin/) software.
Pulsed-ﬁeld gel electrophoresis (PFGE)
All isolates were typed by PFGE [21] following digestion of
intact genomic DNA with ApaI (Promega). DNA fragments
were separated on agarose 1% w ⁄v gels in 0.5· TBE buffer
(1· TBE buffer comprises 89 mM Tris, 89 mM boric acid, 2 mM
EDTA) at 14C using a CHEF DRII apparatus (Bio-Rad) with
6 V ⁄ cm, pulsed from 5 to 35 s, for 24 h. Gels were stained with
ethidium bromide and scanned using the Diversity Database
software image-capturing system. Analysis of the gels was
performed using BioNumerics v.4.0 (Applied Maths, Sint-
Martins-Latem, Belgium). Similarity was calculated using the
Dice coefﬁcient with a tolerance of 1.3% and the unweighted
pair-group method using arithmetic averages (UPGMA).
MICs
All isolates were tested for their susceptibility to imipenem
and meropenem. MICs were determined by doubling dilutions
in agar, according to the British Society for Antimicrobial
Chemotherapy (BSAC) methodology [22]. The results were
interpreted according to the guidelines of the BSAC [23].
Pseudomonas aeruginosa NCTC 10662, Escherichia coli NCTC
10418 and Staphylococcus aureus NCTC 6571 were used as
quality control strains.
Sequence groups
Multiplex PCRs for identiﬁcation of the ompA, csuE and
blaOXA-51-like sequence groupings were performed as described
by Turton et al. [18], except that each reaction used a Ready-to-
Go PCR Bead (GE Healthcare Life Sciences, Little Chalfont,
UK) containing pre-formulated PCR buffer, dNTPs and Taq
polymerase in a ﬁnal reaction volume of 25 lL.
OXA-51-like enzyme linkage map
All publicly available OXA-51-like amino-acid sequences were
obtained from the National Center for Biotechnology Informa-
tion website (http://www.ncbi.nlm.nih.gov/). Sequences were
analysed using MultAlin software (http://bioinfo.genopole-
toulouse.prd.fr/multalin/) and all amino-acid variations were
recorded.OXA-69was chosen as a starting point in constructing
the map, as this was the enzyme found in the oldest isolate in
this study (strain A1, isolated in 1982). The map was subse-
quently re-drawnwith OXA-65 as a starting point (see Results).
Branches were constructed for each enzyme by listing the
amino-acid changes from OXA-65, from the most common
across all enzymes ﬁrst, to the least common last. The branches
were drawn in order, from the enzymes with the fewest
differences from OXA-65 ﬁrst, through to the enzymes with
the highest number of differences. Branches with the same
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Fig. 1. Pulsed-ﬁeld gel electrophoresis proﬁles for strains of Acinetobacter baumannii, showing imipenem and meropenem
MICs, OXA-51-like b-lactamase types, the presence of ISAba1 upstream of the blaOXA-51-like gene, and sequence group types.
IMI, imipenem; MER, meropenem; STG, sequence type group.
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changes within them were merged to produce the fewest
number of branches possible. Amino-acid changes were not
reversed within the same branch.
RESULTS
Sequence groups and blaOXA-51-like sequence
analysis
All experimental results are summarised in Fig. 1.
SG1 formed the largest group, accounting for 47%
of the isolates. The second largest group was SG2,
containing 30% of the isolates, and SG3 was the
smallest group, representing 10% of the isolates.
Representatives of the three European lineages
were found in separate sequence groups, with
EC1 belonging to SG2, EC2 belonging to SG1, and
EC3 belonging to SG3, as described previously
[18]. Eight (13%) isolates did not belong to any of
the three major sequence groups, and produced
novel combinations of products in the two multi-
plex PCRs.
The majority of isolates yielded a blaOXA-66,
blaOXA-69 or a blaOXA-71 sequence; blaOXA-66 was
found in 22 (37%) isolates, blaOXA-69 was found in
14 (23%) isolates, and blaOXA-71 was found in six
(10%) isolates. Sequences corresponding to the
other enzymes were found in one or two isolates
only, except for blaOXA-107, which was found in
three isolates. The sequence from isolate A92 had
ﬁve nucleotide substitutions compared with the
published blaOXA-69 sequence (G426 ﬁ A,
C474 ﬁ A, C511 ﬁ T, G540 ﬁ A and T801 ﬁ C),
but none of these resulted in an amino-acid
change. The representative isolates of EC1
(A297), EC2 (A320) and EC3 (A478) encoded
OXA-69, OXA-66 and OXA-71, respectively. Ten
isolates (17%) were found to contain an ISAba1
element seven nucleotides upstream of their
blaOXA-51-like gene.
PFGE proﬁle analysis revealed that the isolates
varied considerably, with very few distinct
groups. Six pairs of isolates and two groups of
three isolates clustered at ‡87% similarity, which
is a cut-off value that has been suggested for use
in identifying isolates belonging to the same
epidemic strain [24]. The majority (52%) of
isolates shared £78% similarity. Some isolates
with different blaOXA-51-like sequences, and belong-
ing to different sequence groups, were more
similar to one another, according to PFGE anal-
ysis, than they were to isolates that contained the
same blaOXA-51-like gene and belonged to the same
sequence group. Thus, isolate A186, which
belonged to SG1 and contained a blaOXA-66 gene,
shared 80% identity with isolate A335, which
belonged to SG2 and contained a blaOXA-69 gene.
Similarly, isolate A368, which belonged to SG2
and contained a blaOXA-112 gene, shared 82%
identity with isolate A457, which contained a
blaOXA-106 gene and belonged to a novel sequence
group. When isolates were from the same loca-
tion, contained the same blaOXA-51-like gene, and
belonged to the same sequence group, they
tended to form more closely related clusters. This
can be seen with isolates A480, A484, A481 and
A482 from Nottingham, UK. These isolates rep-
resent a dominant clone in the particular hospital
from which the isolates were taken.
Susceptibility testing
The majority (60%) of isolates included in the
study were susceptible to both imipenem and
meropenem according to BSAC criteria. Resis-
tance to imipenem or meropenem or both was
seen in nine isolates. Of the four imipenem- and
meropenem-resistant isolates, three were from
Spain, and all contained one of the three most
common enzymes; A332, A380 and A369 had a
blaOXA-66 sequence, while A329 had a blaOXA-71
sequence. Of the ﬁve isolates that were resistant
only to meropenem, three encoded less common
enzymes that were closely related to OXA-66 or
OXA-69: A371 encoded OXA-83, A401 encoded
OXA-82, and A424 encoded OXA-107.
OXA-51-like enzyme linkage map
The linkage map revealed that the enzymes
formed distinct groupings (Fig. 2). Three very
closely inter-related enzyme groups, with each
Table 1. Primers used in this study
Primer Sequence (5¢–3¢) Reference
OXA-69A CTAATAATTGATCTACTCAAG [12]
OXA-69B CCAGTGGATGGATGGATAGATTATC [12]
preABprom+ GACCTGCAAAGAAGCGCTGC [20]
Group1ompAF306 GATGGCGTAAATCGTGGTA [18]
Group1and2ompAR660 CAACTTTAGCGATTTCTGG [18]
Group1csuEF CTTTAGCAAACATGACCTACC [18]
Group1csuER TACACCCGGGTTAATCGT [18]
Gp1OXA66F89 GCGCTTCAAAATCTGATGTA [18]
Gp1OXA66R647 GCGTATATTTTGTTTCCATTC [18]
Group2ompAF378 GACCTTTCTTATCACAACGA [18]
Group2csuEF GGCGAACATGACCTATTT [18]
Group2csuER CTTCATGGCTCGTTGGTT [18]
Gp2OXA69F169 CATCAAGGTCAAACTCAA [18]
Gp2OXA69R330 TAGCCTTTTTTCCCCATC [18]
Evans et al. OXA-51-like b-lactamases in A. baumannii 271
 2008 The Authors
Journal Compilation  2008 European Society of Clinical Microbiology and Infectious Diseases, CMI, 14, 268–275
member separated by one or two amino-acid
differences, were formed around OXA-66,
OXA-69 and OXA-98. Two other major enzyme
groups were not as closely inter-related. In the
group containing OXA-71, differences at ﬁve
positions separated OXA-71 and OXA-99. The
second group had OXA-108 separated from
OXA-104, also by changes at ﬁve positions.
OXA-67, OXA-86 and OXA-87 formed a chain
rather than a cluster. The three enzymes repre-
sentative of SG1, SG2 and SG3 were not closely
related, with changes at four positions between
OXA-66 and OXA-69, ﬁve positions between
OXA-66 and OXA-71, and seven positions
between OXA-69 and OXA-71. The OXA-66 clus-
ter was the largest group, with ten members
(OXA-66, OXA-65, OXA-88, OXA-76, OXA-109,
OXA-82, OXA-83, OXA-84, OXA-79 and OXA-80).
A member of this group, OXA-65, appeared to
form a central hub within the map from which all
the major branches radiated. The OXA-69 cluster
had ﬁve members (OXA-69, OXA-92, OXA-107,
OXA-110 and OXA-112), as did the OXA-98
cluster (OXA-98, OXA-91, OXA-68, OXA-77 and
OXA-78). In contrast, OXA-71 was closely related
only to OXA-64 and, unlike OXA-66, OXA-69 and
OXA-98, was not a group hub, but was instead
found on a branch tip.
DISCUSSION
Construction of a map showing the relationships
among the OXA-51-like enzymes revealed that
the representative enzymes found in SG1, SG2
and SG3 belonged to separate groups. OXA-66
and OXA-69 appear to be ancestral to their groups
of very closely related enzymes. Such a high
degree of conservation of the OXA-66 cluster and
OXA-69 cluster, relative to the rest of the OXA-51-
like enzymes, is consistent with these enzymes
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belonging to highly successful lineages such as
EC1 and EC2. By multiplex PCR sequence typing,
the isolates encoding the members of the OXA-66
cluster were all assigned to SG1, and all except
two (A92 and A388) of the isolates encoding the
OXA-69 cluster were assigned to SG2, demon-
strating that they contain the same ompA and csuE
alleles as well as blaOXA-51-like alleles. This sug-
gests that the similarities within these isolates
extend not just to the blaOXA-51-like b-lactamase
gene, but also to other genes potentially involved
in the successful colonisation and infection of
patients.
Two isolates, A92 and A388, encoded OXA-69-
clustered enzymes, but did not belong to SG2.
Both isolates were positive within the group 2
multiplex PCR for the blaOXA-51-like amplicon, but
both differed from other SG2 isolates in that they
failed to yield a csuE amplicon in the group 2
multiplex PCR (data not shown). These two
isolates, and the six other isolates which were
not assigned to a sequence group, may represent
strains that are capable of causing outbreaks of
infection in particular locations, but that are
unable to establish themselves more widely in
competition with other more successful epidemic
lineages. Comparisons of such isolates with
members of the more prevalent lineages may
provide insights into the factors involved in
successful epidemic spread. It would be interest-
ing to determine the sequence groups of a range
of isolates representing all of the OXA-51-like
enzymes in order to determine whether there are
other small sequence groups, such as SG3, which
may represent future highly successful lineages
such as SG1 and SG2.
The enzyme linkage map shows that OXA-65 is
a central hub from which all of the major
groupings radiate. To progress from OXA-69 to
the other major groupings would require the
unlikely event of multiple substitutions at the
same amino-acid position. This suggests that
blaOXA-65, or an as yet undiscovered closely
related gene sequence, may be ancestral to all
blaOXA-51-like genes in A. baumannii. Previously,
isolates from 1982, 1983 and 1984 were found to
encode OXA-51, OXA-78 and OXA-89, respec-
tively [14]. These enzymes are not closely related
to OXA-66 or OXA-69, which suggests that much
of the diversity of the OXA-51-like enzymes had
evolved before A. baumannii was identiﬁed as a
signiﬁcant nosocomial pathogen.
The enzyme linkage map demonstrates that the
OXA-66 cluster forms the largest group of closely
related enzymes. In the present study, isolates
encoding enzymes in the OXA-66 cluster formed
the largest group, accounting for 45% of all
isolates. The second largest enzyme group, the
OXA-69 cluster, formed the second largest isolate
group, accounting for 33% of isolates. Isolates
encoding OXA-71 accounted for only 10% of
the total. In this study of mainly European
A. baumannii isolates, SG1 was by far the most
proliﬁc, suggesting that EC2 is part of an exten-
sive lineage that is well-established and exhibits
little variation in certain genes involved in viru-
lence. This is mirrored in the enzyme linkage
map, with the OXA-66 cluster being the largest,
but also being highly conserved. The same is true
for SG2, although this lineage, containing EC1, is
slightly less proliﬁc. SG3 ⁄EC3 is different, in that
it is associated with only one enzyme, OXA-71.
SG3 was not nearly as prevalent in this study as
the other two sequence groups, although this
clone may well have been more highly repre-
sented had more isolates been included from the
Iberian peninsular. While the enzyme linkage
map shows a closely related group surrounding
OXA-98, only three isolates in this study encoded
enzymes belonging to this cluster, indicating that
these enzymes are not associated with predomi-
nant lineages. The most recently identiﬁed en-
zymes largely branch from the main cluster foci,
suggesting that the evolution of these enzymes is
progressing in real-time.
ISAba1 was detected upstream of blaOXA-51-like
genes in only ten isolates. Nine of these were
resistant or had intermediate MICs of at least one
carbapenem; however, these accounted for only
37.5% of such isolates, demonstrating that this
feature was not responsible for conferring carba-
penem resistance in the majority of isolates. The
ISAba1 sequences were all found upstream of
more recently identiﬁed, branch-tip enzymes. The
reason for this is unknown. The ability of mobile
elements such as ISAba1 to insert upstream of the
blaOXA-51-like genes presents the possibility of their
past or future mobilisation.
As might be expected from such a broad range
of isolates, there was a large degree of genomic
variation among the isolates. It is interesting to
note that isolates can be more closely related,
according to PFGE, to an isolate of a different
sequence group than they are to other members of
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their own sequence group. Previously it was
shown that isolates of major outbreak strains with
related PFGE patterns all corresponded to a
speciﬁc sequence group, while the sporadic iso-
lates did not [18]. The data presented here
indicate that non-major outbreak isolates can also
be assigned to one of the three identiﬁed sequence
groups, although this is not always the case, and
that isolates of the same sequence group are not
always related according to PFGE. A. baumannii is
known to contain a variety of mobile elements,
such as ISAba1, often in multiple copies, and the
movement of such elements, along with the
possibility of natural transformation, as seen in
other Acinetobacter spp., could contribute to the
genomic variation observed [25,26].
If blaOXA-51-like genes are immobile, it would be
expected that isolates containing closely related
enzymes would generally be more closely related
to one another than to isolates containing dis-
tantly related enzymes. In addition, sequence
typing of two further genes such as ompA and
csuE should reduce still further any differences
seen between PFGE typing and sequence typing.
The apparent disparity between the two typing
schemes in these data raises important questions
as to the appropriateness of these schemes for
A. baumannii. Further work to determine their
suitability is required.
ACKNOWLEDGEMENTS
This work was funded by the UK Medical Research Council
(grant no. RA0119). The authors would like to thank
N. Woodford, F. Tenover, Z. Gu¨lay, P. Higgins and partici-
pants in the EU ARPAC project for kindly providing isolates of
A. baumannii. L. Dijkshoorn is thanked for providing previ-
ously characterised reference strains belonging to European
clones I, II and III. S. G. B. Amyes has received an educational
grant from Astra-Zeneca. The authors declare that they have
no other conﬂicts of interest in relation to this work.
REFERENCES
1. Bergogne-Berezin E, Towner KJ. Acinetobacter spp., as
nosocomial pathogens: microbiological, clinical, and epi-
demiological features. Clin Microbiol Rev 1996; 9: 148–165.
2. Falagas ME, Bliziotis IA, Siempos II X. Attributable mor-
tality of Acinetobacter baumannii infections in critically ill
patients: a systematic review of matched cohort and case-
control studies. Crit Care 2006; 10: R48.
3. Brown S, Amyes S. OXA beta-lactamases in Acinetobacter:
the story so far. J Antimicrob Chemother 2006; 57: 1–3.
4. Richet HM, Mohammed J, McDonald LC, Jarvis WR.
Building communication networks: international network
for the study and prevention of emerging antimicrobial
resistance. Emerg Infect Dis 2001; 7: 319–322.
5. Manikal VM, Landman D, Saurina G, Oydna E, Lal H,
Quale J. Endemic carbapenem-resistant Acinetobacter
species in Brooklyn, New York: citywide prevalence,
interinstitutional spread, and relation to antibiotic usage.
Clin Infect Dis 2000; 31: 101–106.
6. Dijkshoorn L, Aucken H, GernerSmidt P et al. Comparison
of outbreak and nonoutbreak Acinetobacter baumannii
strains by genotypic and phenotypic methods. J Clin
Microbiol 1996; 34: 1519–1525.
7. van Dessel H, Dijkshoorn L, van der Reijden T et al.
Identiﬁcation of a new geographically widespread multi-
resistant Acinetobacter baumannii clone from European
hospitals. Res Microbiol 2004; 155: 105–112.
8. Da Silva G, Dijkshoorn L, van der Reijden T, van Strijen B,
Duarte A. Identiﬁcation of widespread, closely related
Acinetobacter baumannii isolates in Portugal as a subgroup
of European clone II. Clin Microbiol Infect 2007; 13: 190–195.
9. Donald HM, Scaife W, Amyes SGB, Young HK. Sequence
analysis of ARI-1, a novel OXA beta-lactamase, responsi-
ble for imipenem resistance in Acinetobacter baumannii
6B92. Antimicrob Agents Chemother 2000; 44: 196–199.
10. Heritier C, Poirel L, Lambert T, Nordmann P. Contribution
of acquired carbapenem-hydrolyzing oxacillinases to
carbapenem resistance in Acinetobacter baumannii. Anti-
microb Agents Chemother 2005; 49: 3198–3202.
11. Brown S, Young HK, Amyes SGB. Characterisation of
OXA-51, a novel class D carbapenemase found in geneti-
cally unrelated clinical strains of Acinetobacter baumannii
from Argentina. Clin Microbiol Infect 2005; 11: 15–23.
12. Heritier C, Poirel L, Fournier PE, Claverie JM, Raoult D,
Nordmann P. Characterization of the naturally occurring
oxacillinase of Acinetobacter baumannii. Antimicrob Agents
Chemother 2005; 49: 4174–4179.
13. Brown S, Amyes SGB. The sequences of seven class D
beta-lactamases isolated from carbapenem-resistant
Acinetobacter baumannii from four continents. Clin Microbiol
Infect 2005; 11: 326–329.
14. Merkier AK, Centron D. blaOXA-51-type beta-lactamase
genes are ubiquitous and vary within a strain in Acineto-
bacter baumannii. Int J Antimicrob Agents 2006; 28: 110–113.
15. Evans BA, Brown S, Hamouda A, Findlay J, Amyes SG.
Eleven novel OXA-51-like enzymes from clinical isolates
of Acinetobacter baumannii. Clin Microbiol Infect 2007; 13:
1137–1138.
16. Turton JF, Ward ME, Woodford N et al. The role of ISAba1
in expression of OXA carbapenemase genes in Acineto-
bacter baumannii. FEMS Microbiol Lett 2006; 258: 72–77.
17. Turton JF, Woodford N, Glover J, Yarde S, Kaufmann ME,
Pitt TL. Identiﬁcation of Acinetobacter baumannii by detec-
tion of the blaOXA-51-like carbapenemase gene intrinsic to
this species. J Clin Microbiol 2006; 44: 2974–2976.
18. Turton JF, Gabriel SN, Valderrey C, Kaufmann ME, Pitt
TL. Use of sequence-based typing and multiplex PCR to
identify clonal lineages of outbreak strains of Acinetobacter
baumannii. Clin Microbiol Infect 2007; 13: 807–815.
19. Ehrenstein B, Bernards AT, Dijkshoorn L et al. Acinetobac-
ter species identiﬁcation by using tRNA spacer ﬁnger-
printing. J Clin Microbiol 1996; 34: 2414–2420.
20. Heritier C, Poirel L, Nordmann P. Cephalosporinase over-
expression resulting from insertion of ISAba1 in Acineto-
bacter baumannii. Clin Microbiol Infect 2006; 12: 123–130.
274 Clinical Microbiology and Infection, Volume 14 Number 3, March 2008
 2008 The Authors
Journal Compilation  2008 European Society of Clinical Microbiology and Infectious Diseases, CMI, 14, 268–275
21. Miranda G, Kelly C, Solorzano F, Leanos B, Coria R,
Patterson JE. Use of pulsed-ﬁeld gel electrophoresis typing
to study an outbreak of infection due to Serratia marcescens
in a neonatal intensive care unit. J Clin Microbiol 1996; 34:
3138–3141.
22. Anonymous. A guide to sensitivity testing. Report of the
Working Party on Antibiotic Sensitivity Testing of the
British Society for Antimicrobial Chemotherapy. J Anti-
microb Chemother 1991; 27 (suppl D): 1–50.
23. Andrews JM. BSAC standardized disc susceptibility test-
ing method (version 6). J Antimicrob Chemother 2007; 60:
20–41.
24. Seifert H, Dolzani L, Bressan R et al. Standardization and
interlaboratory reproducibility assessment of pulsed-ﬁeld
gel electrophoresis-generated ﬁngerprints of Acinetobacter
baumannii. J Clin Microbiol 2005; 43: 4328–4335.
25. Segal H, Garny S, Elisha BG. Is ISABA-1 customized for
Acinetobacter? FEMS Microbiol Lett 2005; 243: 425–429.
26. Palmen R, Hellingwerf KJ. Uptake and processing of DNA
by Acinetobacter calcoaceticus—a review. Gene 1997; 192:
179–190.
Evans et al. OXA-51-like b-lactamases in A. baumannii 275
 2008 The Authors
Journal Compilation  2008 European Society of Clinical Microbiology and Infectious Diseases, CMI, 14, 268–275
